$ZBIO 8-K SEC Filings

Filed On	Filing
13 Oct 2026	8-K: Regulation FD Disclosure Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease
13 Aug 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
13 May 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
31 Mar 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
16 Mar 2026	8-K: Results of Operations and Financial Condition
13 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
05 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
15 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
12 Nov 2025	8-K: Results of Operations and Financial Condition
27 Oct 2025	8-K: Regulation FD Disclosure; Other Events
08 Oct 2025	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +3 more
02 Sep 2025	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more
12 Aug 2025	8-K: Results of Operations and Financial Condition
12 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
04 Jun 2025	8-K: Regulation FD Disclosure
15 May 2025	8-K: Results of Operations and Financial Condition
05 Feb 2025	8-K: Results of Operations and Financial Condition
02 Dec 2024	8-K: Regulation FD Disclosure
12 Nov 2024	8-K: Results of Operations and Financial Condition
16 Sep 2024	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

Comments